BRPI0809958A2 - conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver 5 uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico - Google Patents

conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver 5 uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico

Info

Publication number: BRPI0809958A2
Authority: BR; Brazil
Prior art keywords: hpv; spheres; strains; differentiating; risk
Prior art date: 2007-04-05

Application number

Other languages

English (en)

Inventor

Daniel J Park

Karl F Poetter

Zaheer Khan

Original Assignee

Genera Biosystems Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-04-05

Filing date

2008-04-04

Publication date

2008-10-16

2008-04-04 Application filed by Genera Biosystems Ltd filed Critical Genera Biosystems Ltd

2008-10-16 Publication of BRPI0809958A2 publication Critical patent/BRPI0809958A2/pt

2020-12-01 Publication of BRPI0809958B1 publication Critical patent/BRPI0809958B1/pt

2021-06-15 Publication of BRPI0809958B8 publication Critical patent/BRPI0809958B8/pt

2021-07-27 Publication of BRPI0809958C1 publication Critical patent/BRPI0809958C1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

BRPI0809958A 2007-04-05 2008-04-04 conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico BRPI0809958C1 (pt)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US91038107P	2007-04-05	2007-04-05
US91037307P	2007-04-05	2007-04-05
US60/910,373		2007-04-05
US60/910,381		2007-04-05
PCT/US2008/004441 WO2008124091A2 (en)	2007-04-05	2008-04-04	Compositions and methods of detection

Publications (4)

Publication Number	Publication Date
BRPI0809958A2 true BRPI0809958A2 (pt)	2008-10-16
BRPI0809958B1 BRPI0809958B1 (pt)	2020-12-01
BRPI0809958B8 BRPI0809958B8 (pt)	2021-06-15
BRPI0809958C1 BRPI0809958C1 (pt)	2021-07-27

Family

ID=39831523

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0809958A BRPI0809958C1 (pt)	2007-04-05	2008-04-04	conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico

Country Status (11)

Country	Link
US (2)	US8278429B2 (pt)
EP (1)	EP2142926B1 (pt)
JP (1)	JP2010523114A (pt)
CN (1)	CN101730847B (pt)
AU (1)	AU2008236678B2 (pt)
BR (1)	BRPI0809958C1 (pt)
ES (1)	ES2403729T3 (pt)
MX (1)	MX2009010751A (pt)
NZ (1)	NZ580242A (pt)
RU (1)	RU2480732C2 (pt)
WO (1)	WO2008124091A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005116615A1 (en)	2004-05-26	2005-12-08	Genera Biosystems Pty Ltd	Biosensor using whispering gallery modes in microspheres
EP2142926B1 (en) *	2007-04-05	2012-12-05	Genera Biosystems Limited	Compositions and methods of detection
US10679749B2 (en) *	2008-08-22	2020-06-09	International Business Machines Corporation	System and method for virtual world biometric analytics through the use of a multimodal biometric analytic wallet
WO2011088573A1 (en) *	2010-01-19	2011-07-28	Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health	Set of probes for the detection and typing of 46 human papillomavirus mucosal types
US8263388B2 (en) *	2010-06-10	2012-09-11	The Hong Kong Polytechnic University	Method and apparatus for detecting specific DNA sequences
WO2013049891A1 (en) *	2011-10-04	2013-04-11	Genera Biosystems Limited	Compositions and methods of detecting respiratory pathogens using nucleic acid probes and subsets of beads
US10640807B2 (en) *	2011-12-29	2020-05-05	S.D. Sight Diagnostics Ltd	Methods and systems for detecting a pathogen in a biological sample
AT521238B1 (de)	2018-05-09	2020-02-15	Lifetaq Analytics Gmbh	In-situ zellanalyse im zellkultursystem
RU2734957C1 (ru) *	2020-04-20	2020-10-26	Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук	Биомедицинский материал для диагностики патологий в биологических тканях
RU2766938C1 (ru) *	2021-06-30	2022-03-16	Александр Федорович Попов	Способ выполнения космохимического исследования

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5411857A (en) *	1985-07-31	1995-05-02	Institut Nationale De La Sante	Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections
CA1276575C (fr) *	1984-11-30	1990-11-20	Sylvie Beaudenon	Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
US5876922A (en) *	1985-07-31	1999-03-02	Institute Pasteur	Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections
KR930007580B1 (ko) *	1986-03-21	1993-08-13	엥스띠뛰 빠스뙤르	유두종 비루스 게놈으로부터 유도된 결정 dna 서열, 그의 시험관내 진단 목적용 용도 및 항원 조성물의 제조 방법
AU619170B2 (en) *	1987-01-09	1992-01-23	Abbott Laboratories	Diagnostic assays using nucleic acid probes
FR2629458B2 (fr) *	1987-07-31	1991-08-09	Ire Celltarg Sa	Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5447839A (en) *	1988-09-09	1995-09-05	Hoffmann-La Roche Inc.	Detection of human papillomavirus by the polymerase chain reaction
US5639871A (en) *	1988-09-09	1997-06-17	Roche Molecular Systems, Inc.	Detection of human papillomavirus by the polymerase chain reaction
CA1339729C (en) *	1988-10-26	1998-03-17	Wayne D. Lancaster	Human papillomavirus type 52 dna sequences and methods for employing thesame
US5580970A (en) *	1989-12-01	1996-12-03	Amoco Corporation	Detection of HPV transcripts
NL9000134A (nl) *	1990-01-19	1991-08-16	Stichting Res Fonds Pathologie	Primers en werkwijze voor het detecteren van humaan papilloma virus genotypen m.b.v. pcr.
US5484699A (en) *	1990-09-28	1996-01-16	Abbott Laboratories	Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
FR2670797A1 (fr) *	1990-12-20	1992-06-26	Pasteur Institut	Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
EP0523391B1 (en) *	1991-07-13	2003-03-19	Dade Behring Marburg GmbH	Use of HPV-16 E6 and E7-gene derived peptides for the diagnostic purpose
US5346811A (en) *	1991-07-22	1994-09-13	Cerveceria Polar	Method and products for human papillomavirus detection
WO1995022626A1 (en) *	1994-02-21	1995-08-24	Stichting Researchfonds Pathologie	Human papilloma virus detection in a nucleic acid amplification process using general primers
CA2163393C (en) *	1994-11-30	2003-04-22	Colleen Marie Nycz	Amplification and detection of mycobacteria nucleic acids
US5981180A (en) *	1995-10-11	1999-11-09	Luminex Corporation	Multiplexed analysis of clinical specimens apparatus and methods
CA2237891C (en) *	1995-11-15	2013-07-30	Gen-Probe Incorporated	Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
US6511805B1 (en) *	1996-03-15	2003-01-28	The Penn State Research Foundation	Methods for detecting papillomavirus DNA in blood plasma and serum
US6265154B1 (en) *	1996-10-25	2001-07-24	Abbott Laboratories	Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
ES2180207T3 (es) *	1997-09-16	2003-02-01	Innogenetics Nv	Deteccion e identificacion del papilomavirus humano por medio de pcr y de hibridacion inversa de tipo especifico.
ZA989950B (en) *	1997-11-17	1999-05-04	Akzo Nobel Nv	Transcription based amplification of double stranded DNA targets
AU6695600A (en) *	1999-07-19	2001-02-05	Cambridge University Technical Services Limited	A method for amplifying low abundance nucleic acid sequences and means for performing said method
US7601497B2 (en) *	2000-06-15	2009-10-13	Qiagen Gaithersburg, Inc.	Detection of nucleic acids by target-specific hybrid capture method
WO2002039083A2 (en) *	2000-11-08	2002-05-16	Science & Technology Corporation @ Unm	Fluorescence and fret based assays for biomolecules on beads
ATE348192T1 (de)	2001-08-23	2007-01-15	Merck & Co Inc	Multiplex-hpv-pcr-fluoreszenzassays unter verwendung mehrerer fluorophore
WO2003054149A2 (en) *	2001-12-07	2003-07-03	University Of Massachusetts	Targeted genetic risk-stratification using microarrays
WO2005033333A2 (en) *	2003-10-07	2005-04-14	Dako Denmark A/S	Methods and compositions for the diagnosis of cancer
WO2006060872A1 (en) *	2004-12-10	2006-06-15	Genera Biosystems Pty Ltd	Human papilloma virus (hpv) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (facs)
ES2524050T3 (es) *	2004-12-10	2014-12-03	Genera Biosystems Limited	Detección del virus del papiloma humano (VPH) usando sondas de ácidos nucleicos, microperlas y clasificadores celulares activados por fluorescencia (FACS)
CA2592078A1 (en) *	2004-12-23	2006-06-29	Human Genetic Signatures Pty Ltd	Detection of human papilloma virus
GB0500996D0 (en) *	2005-01-18	2005-02-23	Delfts Diagnostic Labaratory B	Detection method and materials therefor
EP2142926B1 (en) *	2007-04-05	2012-12-05	Genera Biosystems Limited	Compositions and methods of detection

2008
- 2008-04-04 EP EP08727296A patent/EP2142926B1/en not_active Not-in-force
- 2008-04-04 JP JP2010502147A patent/JP2010523114A/ja active Pending
- 2008-04-04 MX MX2009010751A patent/MX2009010751A/es active IP Right Grant
- 2008-04-04 AU AU2008236678A patent/AU2008236678B2/en not_active Ceased
- 2008-04-04 CN CN200880019228.8A patent/CN101730847B/zh not_active Expired - Fee Related
- 2008-04-04 ES ES08727296T patent/ES2403729T3/es active Active
- 2008-04-04 RU RU2009140736/15A patent/RU2480732C2/ru not_active IP Right Cessation
- 2008-04-04 WO PCT/US2008/004441 patent/WO2008124091A2/en not_active Ceased
- 2008-04-04 NZ NZ580242A patent/NZ580242A/en not_active IP Right Cessation
- 2008-04-04 US US12/594,817 patent/US8278429B2/en not_active Expired - Fee Related
- 2008-04-04 BR BRPI0809958A patent/BRPI0809958C1/pt not_active IP Right Cessation
2012
- 2012-06-04 US US13/488,212 patent/US20130184170A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2008124091A3 (en)	2009-01-15
JP2010523114A (ja)	2010-07-15
US20100279888A1 (en)	2010-11-04
NZ580242A (en)	2012-02-24
WO2008124091A2 (en)	2008-10-16
EP2142926A4 (en)	2010-08-04
BRPI0809958B8 (pt)	2021-06-15
CN101730847A (zh)	2010-06-09
ES2403729T3 (es)	2013-05-21
BRPI0809958B1 (pt)	2020-12-01
US8278429B2 (en)	2012-10-02
RU2480732C2 (ru)	2013-04-27
AU2008236678A1 (en)	2008-10-16
RU2009140736A (ru)	2011-05-10
MX2009010751A (es)	2010-03-08
EP2142926A2 (en)	2010-01-13
HK1140019A1 (en)	2010-09-30
US20130184170A1 (en)	2013-07-18
AU2008236678B2 (en)	2013-09-12
BRPI0809958C1 (pt)	2021-07-27
EP2142926B1 (en)	2012-12-05
CN101730847B (zh)	2015-03-18

Publication	Publication Date	Title
BRPI0809958A2 (pt)	2008-10-16	conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver 5 uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico
Kroon et al.	2011	Zoonotic Brazilian Vaccinia virus: from field to therapy
Castellanos et al.	2012	Progress in molecular typing of Mycobacterium avium subspecies paratuberculosis
BRPI0812771A2 (pt)	2014-12-02	Método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo, conjunto de reagentes para a realização do método de detecção .
BRPI0814957A2 (pt)	2015-02-03	Composto, pró-droga, agente farmacêutico, método para a profilaxia ou tratamento de uma doença, distúrbio ou condição, e, uso do composto.
WO2009019230A3 (en)	2009-04-23	Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease
WO2011008349A3 (en)	2011-06-09	Methods of identifying infectious disease and assays for identifying infectious disease
JP2017522908A5 (pt)	2018-09-06
WO2008143717A8 (en)	2009-07-30	Methods of determining lethality of pathogens and malignancies involving replikin peak genes
BR112014015851A2 (pt)	2019-09-24	proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17
EP2209468A4 (en)	2012-04-11	CHITOSAN AND PHYTIC ACID CONTAINING CHITOSAN CAPSULES WITH DELAYED RELEASE
BR112015004191A2 (pt)	2017-07-04	chapa de aço
WO2008087040A3 (en)	2008-10-16	Methods and nucleic acids for analyses of cell proliferative disorders
JP2008245635A5 (pt)	2010-12-02
BR112013001020A2 (pt)	2017-07-11	tira de teste de sangue e sistema de cateter intravenoso
BRPI0717753A2 (pt)	2013-10-22	Método de tratamento ou redução do risco de uma doença causada por protozoários, e, composição.
WO2007133682A3 (en)	2008-11-27	100% sequence identity detection methods for variable genomes
BR112012002836A2 (pt)	2015-09-01	Extrato de picrorhiza kurroa para a prevenção, eliminação e tratamento de vírus à base de adn em seres humano e na indústria biotécnica.
BRPI1014222A2 (pt)	2017-05-16	composto, composição farmacêutica,e, métodos para tratar distúrbio(s) cognitivo(s) ou indicações com déficit(s) na cognição, mal de alzheimer, e distúrbio bipolar
BRPI0814247A2 (pt)	2015-01-06	Método para diagnóstico ou classificação de uma infecção por arbovírus, reagentes úteis no dito método e suas aplicações
WO2007006712A3 (en)	2007-04-05	Mycoplasma subunit vaccine
FR2920311B1 (fr)	2010-06-18	Composition solide, orodispersible et/ou dispersible, sans excipient a effet notoire et son procede de preparation
WO2007109733A3 (en)	2008-01-24	Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
WO2008008983A3 (en)	2008-04-24	Methods and nucleic acids for analyses of cellular proliferative disorders
BR112014024601A2 (pt)	2018-04-17	oligonucleotídeos modificados compostos de funções tióis e o uso destes para a detecção de ácidos nucleicos.

Legal Events

Date	Code	Title	Description
2019-08-06	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-11-05	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-02-11	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2020-05-26	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2020-09-15	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-12-01	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/12/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-06-15	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: REF. RPI 2604 DE 01/12/2020 QUANTO AO TITULO.
2021-07-27	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/04/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO
2023-01-31	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 15A ANUIDADE.
2023-05-16	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2717 DE 31-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.